Jupiter Neurosciences raises $2.5M in registered direct offering to maintain Nasdaq listing

JUPITER NEUROSCIENCES, INC.

Sold 307,692 shares at $6.50/share on Aug 21, 2026; gross proceeds ~$2.0M before placement agent fees.
Offering closed Aug 24, 2026; proceeds support stockholders' equity above Nasdaq's $2.5M minimum.
Company awaits Nasdaq's formal compliance determination; delisting risk if next periodic report shows shortfall.
CEO Christer Rosen signed the filing on Aug 24, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.